Researchers found that calculations for predicting appropriate dosing levels of vancomycin for adults with multidrug-resistant Staphylococcus aureus infections were inaccurate for computing the minimum effective dosages for adolescents between ages 10 and 18. The findings appear in the Journal of Clinical Pharmacology.
Antibiotic dosing calculations appear inaccurate for pediatric MRSA infections
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||